rs11581556

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.1187+2661G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.203 in 152,090 control chromosomes in the GnomAD database, including 3,925 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3925 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.114

Publications

9 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007348.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
NM_007348.4
MANE Select
c.1187+2661G>A
intron
N/ANP_031374.2
ATF6
NM_001437597.1
c.1187+2661G>A
intron
N/ANP_001424526.1
ATF6
NM_001410890.1
c.1187+2661G>A
intron
N/ANP_001397819.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
ENST00000367942.4
TSL:1 MANE Select
c.1187+2661G>A
intron
N/AENSP00000356919.3
ATF6
ENST00000681492.1
c.1187+2661G>A
intron
N/AENSP00000506139.1
ATF6
ENST00000680688.1
c.1187+2661G>A
intron
N/AENSP00000504865.1

Frequencies

GnomAD3 genomes
AF:
0.203
AC:
30904
AN:
151972
Hom.:
3927
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0499
Gnomad AMI
AF:
0.369
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.215
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.296
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.279
Gnomad OTH
AF:
0.209
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.203
AC:
30896
AN:
152090
Hom.:
3925
Cov.:
32
AF XY:
0.203
AC XY:
15126
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0498
AC:
2066
AN:
41520
American (AMR)
AF:
0.191
AC:
2921
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
745
AN:
3472
East Asian (EAS)
AF:
0.276
AC:
1425
AN:
5160
South Asian (SAS)
AF:
0.162
AC:
782
AN:
4824
European-Finnish (FIN)
AF:
0.296
AC:
3129
AN:
10560
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.279
AC:
18982
AN:
67956
Other (OTH)
AF:
0.207
AC:
437
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1204
2407
3611
4814
6018
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.253
Hom.:
8584
Bravo
AF:
0.191
Asia WGS
AF:
0.202
AC:
700
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.0
DANN
Benign
0.81
PhyloP100
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11581556; hg19: chr1-161793612; API